Myozyme

Active Ingredient(s): Alglucosidase Alfa
FDA Approved: * April 28, 2006
Pharm Company: * GENZYME
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Myozyme Overview

Alglucosidase alfa (Lumizyme, Myozyme, Genzyme) is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD).[3] Chemically speaking, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.[1] Contents 1 Status 2 Side effects 3 References 4 External link...

Read more Myozyme Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alglucosidase_alfa

Recent Myozyme Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alglucosidase Alfa
  • Injection: 20mg/kg
  • Powder: 5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Myozyme: (1 result)

Sorted by National Drug Code
  • 58468-0150 Myozyme 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation

Other drugs which contain Alglucosidase Alfa or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA